» Articles » PMID: 15940668

Association of CTLA4 Polymorphism with Regulatory T Cell Frequency

Overview
Journal Eur J Immunol
Date 2005 Jun 9
PMID 15940668
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

A common single nucleotide polymorphism in CTLA4 has been linked with susceptibility and outcome in autoimmune and infectious diseases, respectively. Here, we show that this polymorphism is associated with the frequency of CD4(+)CD25(+) regulatory T cells in healthy human volunteers. We further show that, on a per cell basis, such regulatory T cells appear to be functionally indistinguishable across CTLA4 genotypes. These data implicate CTLA4 in regulatory T cell development, and provide a mechanism to account for the link between polymorphisms at this locus and the biological outcome of adaptive immune responses to self and to pathogens.

Citing Articles

Association of four CTLA-4 gene polymorphisms with pemphigus risk: a systematic review, meta-analysis, and meta-regression.

Dhaouadi T, Riahi A, Ben Abdallah T, Gorgi Y, Sfar I J Int Med Res. 2024; 52(10):3000605241282116.

PMID: 39397428 PMC: 11529675. DOI: 10.1177/03000605241282116.


Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes.

Newman J, Long S, Speake C, Greenbaum C, Cerosaletti K, Rich S Commun Biol. 2023; 6(1):988.

PMID: 37758901 PMC: 10533491. DOI: 10.1038/s42003-023-05327-7.


The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.

Pang H, Luo S, Huang G, Li X, Xie Z, Zhou Z Biochem Genet. 2021; 60(4):1222-1235.

PMID: 34822071 DOI: 10.1007/s10528-021-10152-w.


Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications.

Comba A, Faisal S, Varela M, Hollon T, Al-Holou W, Umemura Y Front Oncol. 2021; 11:703764.

PMID: 34422657 PMC: 8377724. DOI: 10.3389/fonc.2021.703764.


Cytotoxic T-lymphocyte Antigen-4 () Gene Polymorphism (rs3087243) Is Related to Risk and Survival in Patients With Colorectal Cancer.

VAN Nguyen S, Shamoun L, Landerholm K, Andersson R, Wagsater D, Dimberg J In Vivo. 2021; 35(2):969-975.

PMID: 33622891 PMC: 8045117. DOI: 10.21873/invivo.12339.